Page last updated: 2024-10-21

pk 11195 and Clinically Isolated CNS Demyelinating Syndrome

pk 11195 has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 3 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Visigalli, I1
Moresco, RM1
Belloli, S1
Politi, LS1
Gritti, A1
Ungaro, D1
Matarrese, M1
Turolla, E1
Falini, A1
Scotti, G1
Naldini, L1
Fazio, F1
Biffi, A1
Chen, MK2
Baidoo, K1
Verina, T1
Guilarte, TR2

Other Studies

3 other studies available for pk 11195 and Clinically Isolated CNS Demyelinating Syndrome

ArticleYear
Monitoring disease evolution and treatment response in lysosomal disorders by the peripheral benzodiazepine receptor ligand PK11195.
    Neurobiology of disease, 2009, Volume: 34, Issue:1

    Topics: Animals; Brain; Carbon Radioisotopes; Central Nervous System Diseases; Demyelinating Diseases; Disea

2009
Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization.
    Brain : a journal of neurology, 2004, Volume: 127, Issue:Pt 6

    Topics: Animals; Astrocytes; Autoradiography; Biomarkers; Cerebral Cortex; Cuprizone; Demyelinating Diseases

2004
Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination.
    Toxicological sciences : an official journal of the Society of Toxicology, 2006, Volume: 91, Issue:2

    Topics: Animals; Corpus Callosum; Cuprizone; Demyelinating Diseases; Isoquinolines; Male; Mice; Mice, Inbred

2006